Literature DB >> 20819836

Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project.

Tomohiro Matsuda1, Tomomi Marugame, Ken-ichi Kamo, Kota Katanoda, Wakiko Ajiki, Tomotaka Sobue.   

Abstract

The Japan Cancer Surveillance Research Group estimated the cancer incidence in 2005 as part of the Monitoring of Cancer Incidence in Japan (MCIJ) project, on the basis of data collected from 12 of 30 population-based cancer registries. The total number of incidences in Japan for 2005 was estimated as 646,802 (C00-C96). The leading cancer site was the stomach for men and the breast for women. Age-standardized incidence rates remained almost the same level as the previous 2 years.

Entities:  

Mesh:

Year:  2010        PMID: 20819836     DOI: 10.1093/jjco/hyq169

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  49 in total

1.  S-1 induced secondary acute erythroid leukemia with a chromosome inv(12)(p13;q13).

Authors:  Kensuke Matsumoto; Akira Kitanaka; Makiko Uemura; Fusako Waki; Tetsuya Fukumoto; Hiroaki Ohnishi; Yoshitsugu Kubota; Toshihiko Ishida
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Screening and minimally invasive treatment for gastric cancer are important challenges in elderly patients.

Authors:  Osamu Hosokawa
Journal:  Gastric Cancer       Date:  2012-01       Impact factor: 7.370

3.  Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75 years old.

Authors:  Hideaki Miyake; Iori Sakai; Ken-ichi Harada; Mototsugu Muramaki; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2012-06-24       Impact factor: 2.370

4.  Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.

Authors:  M Kato; T Yamashita; R Suzuki; K Matsumoto; H Nishimori; S Takahashi; K Iwato; C Nakaseko; T Kondo; K Imada; F Kimura; T Ichinohe; Y Hashii; K Kato; Y Atsuta; S Taniguchi; T Fukuda
Journal:  Leukemia       Date:  2016-02-12       Impact factor: 11.528

5.  Severity of complications after gastrectomy in elderly patients with gastric cancer.

Authors:  Tsutomu Hayashi; Takaki Yoshikawa; Toru Aoyama; Takashi Ogata; Haruhiko Cho; Akira Tsuburaya
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

6.  Clinical characteristics and outcomes of patients with small cell lung cancer detected by CT screening.

Authors:  Toshirou Fukushima; Kazunari Tateishi; Hiroshi Yamamoto; Masayuki Hanaoka; Keishi Kubo; Tomonobu Koizumi
Journal:  Med Oncol       Date:  2013-06-06       Impact factor: 3.064

7.  Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx.

Authors:  Satoshi Fujii; Hideoki Uryu; Ken Akashi; Kensuke Suzuki; Manabu Yamazaki; Makoto Tahara; Ryuichi Hayashi; Atsushi Ochiai
Journal:  Int J Clin Oncol       Date:  2012-03-24       Impact factor: 3.402

8.  Condition of muscularis mucosae is a risk factor for lymph node metastasis in T1 colorectal carcinoma.

Authors:  Koichi Nakadoi; Shiro Oka; Shinji Tanaka; Nana Hayashi; Motomi Terasaki; Koji Arihiro; Fumio Shimamoto; Kazuaki Chayama
Journal:  Surg Endosc       Date:  2013-11-27       Impact factor: 4.584

9.  The impact of cardiovascular comorbidities on the outcome of surgery for non-small-cell lung cancer.

Authors:  Tomoyoshi Takenaka; Masakazu Katsura; Yasunori Shikada; Syuichi Tsukamoto; Sadanori Takeo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-05

10.  Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution.

Authors:  Ryu Kanzaki; Masayoshi Inoue; Masato Minami; Yasushi Shintani; Soichiro Funaki; Tomohiro Kawamura; Meinoshin Okumura
Journal:  Surg Today       Date:  2016-05-19       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.